Morgan Stanley Remains a Buy on ​Equifax Inc. (EFX)

​Equifax Inc. (NYSE:EFX) is one of the Best 52-Week Low Stocks to Invest In. On January 26, Toni Kaplan from Morgan Stanley reiterated a Buy rating on the stock with a $269 price target. Earlier, on January 13, Ashish Sabadra from RBC Capital also reiterated a Buy rating on the stock with a $250 price target.

​Analyst Sabadra from RBC Capital sees long-term buying opportunities for credit bureau stocks amidst regulatory concerns. He noted that despite the pressures, fundamentals of the sector remain strong throughout 2026. Sabadra highlighted that Equifax and its peers face short-term stock pressure from regulatory concerns, including the Federal Housing Finance Agency’s shift to bi-merge credit reports, alongside credit card caps, and the Credit Card Competition Act.

​Despite these concerns, the firm believes that the companies in the sector could potentially exceed consensus due to strong mortgage inquiries and steady lending. The firm also identified several tailwinds, including those from OBBA, deregulation, lower rates, and modest mortgage recovery. RBC Capital sees Equifax Inc. (NYSE:EFX) to guide 6% to 8% revenue growth in 2026, along with 8% to 11% adjusted EBITDA growth.

​Equifax Inc. (NYSE:EFX) is a global data, analytics, and technology company that primarily provides credit reporting, identity management, and workforce verification services.

While we acknowledge the potential of EFX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.